Sylvester Comments on FDA Report about CBD

Special Counsel Brian Sylvester was quoted in a Food Navigator-USA article, “FDA report on CBD seen as ‘disappointing’ recap of status quo,” about a report to Congress on CBD by FDA Commissioner Dr. Stephen Hahn.

Sylvester said the report suggests that FDA may be more focused on dietary supplements as a lawful regulatory pathway. “With the release of FDA’s report, we now know that FDA currently views dietary supplements as a potentially more viable pathway than food,” he said.